Savvy Updates 10 April 2018 FOLLOW THE $$: Lilly in our Future, JDRF Early Stage Investment Fund, New Infusion Technology
Eli Lilly ponies up $63M for Sigilon’s diabetes cell therapies, according to Amirah Al Adrus of FierceBiotech.com, 4 April 2018. Eli Lilly is continuing its push into new diabetes products, paying $63 million up front to get its hands on Sigilon Therapeutics’...
Savvy Updates, 10 March 2018: Spider Web “String, Human Insulin Market to $39.13 BILLION, GLP-1, 42 Factors
Spider web inspired implantable “string” could control diabetes, was reported by Rich Haridy on NewAtlas.com medical news, 2 January 2018 as published in the journal Proceedings of the National Academy of Sciences, Cornell Universiity. A team of...
Savvy Updates, 16 December 2017: Dexcom Submits G6, Melt Fat Cells, Semma Tech, Stem Cells for Foot Ulcers, New Blood Glucose Device without Pricks, Lilly Pump, Vaping Insulin?
7 Diabetes Technology Updates for 2018 was published on ASweetLife by Christopher Snider of Tidepool, 8 December 2017. Here’s a glimpse at some of the companies and movements that I am going to pay close attention to next year as diabetes technology looks to take...
Savvy on The Gut Microbiome and Inflammation
The gut microbiome is WAY important for those of us living with diabetes. Now what?
Savvy Updates, 7/8/2017: Novo Nordisk RECALL, Nasal Glucagon, ‘Smart’ Insulin Patch, ‘Smartmat’
Novo Nordisk recalls faulty cartridge holders in insulin pens was announced 5 July 2017. Novo Nordisk said it was initiating a recall of insulin cartridge holders used in some NovoPen Echo insulin pen devices distributed in the United States because the holders...
More Diabetes Blogs